COVID-19 & Wellness Management
OUR SERVICES
PanoHealth is a CLIA certified laboratory providing fast turnaround COVID-19 (SARS-CoV-2) RT-PCR testing. We also offer wellness management programs assessing the evolving, real-time status of current health using protein biomarkers. We seek to better the quality of life for individuals worldwide by providing accurate and comprehensive tests and solutions.
GET IN TOUCH WITH US
PanoHealth, LLC
3607 Parkway Lane, Suite 300
Peachtree Corners, GA
30092
info@panohealth.com
(678) 387-3712
LATEST COVID NEWS
-
Specific Settings
Source: CDC Published on 2023-05-11
-
Redirect - International Travel to and from the United States
Source: CDC Published on 2023-05-09
-
COVID-19 Vaccine Effectiveness
Source: CDC Published on 2023-03-23
-
International Travel to and from the United States
Source: CDC Published on 2023-03-09
-
V-safe After Vaccination Health Checker
Source: CDC Published on 2023-02-26
-
Understanding How COVID-19 Vaccines Work
Source: CDC Published on 2023-02-02
-
Clinical Care Information for COVID-19
Source: CDC Published on 2023-01-29
-
Factors That Affect Your Risk of Getting Very Sick from COVID-19
Source: CDC Published on 2023-01-25
-
Ensuring COVID-19 Vaccine Safety in the US
Source: CDC Published on 2022-12-21
-
Benefits of Getting A COVID-19 Vaccine
Source: CDC Published on 2022-12-21
-
FDA Roundup: May 26, 2023
Source: FDA Published on 2023-05-26
-
FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults
Source: FDA Published on 2023-05-25
-
FDA Approves New Treatment for Pneumonia Caused by Certain Difficult-to-Treat Bacteria
Source: FDA Published on 2023-05-23
-
FDA Roundup: May 23, 2023
Source: FDA Published on 2023-05-23
-
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
Source: FDA Published on 2023-05-23
-
FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose
Source: FDA Published on 2023-05-22
-
FDA Roundup: May 19, 2023
Source: FDA Published on 2023-05-19
-
FDA Approves First Topical Gene Therapy for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa
Source: FDA Published on 2023-05-19
-
FDA Clears New Insulin Pump and Algorithm-Based Software to Support Enhanced Automatic Insulin Delivery
Source: FDA Published on 2023-05-19
-
FDA Roundup: May 16, 2023
Source: FDA Published on 2023-05-16